CClinicalTrials.gg
Not yet recruitingNCT07486336SAFE-AWARENESSUpdated Mar 20, 2026

Awareness Neuraxial Versus General Anesthesia in Frail Patients Undergoing Laparoscopic or Robotic Abdominopelvic Surgery.

An interventional study of Neuraxial anesthesia and General Anesthesia in Fraily, Abdominal Surgery and Postoperative Cognitive Dysfunction (POCD), sponsored by Ente Ospedaliero Ospedali Galliera. Not yet recruiting at 2 sites in Italy. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-03-20.

Sponsored by Ente Ospedaliero Ospedali Galliera · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

This is a bicentric, prospective, non-pharmacological, randomized study designed to compare the efficacy and safety of awake neuraxial anesthesia with sedation versus general anesthesia in frail patients undergoing elective major laparoscopic or robotic abdominopelvic surgery.

A total of 100 frail patients aged over 60 years, with ASA physical status >2 and evidence of frailty and/or cognitive vulnerability, will be randomized to receive either standard general anesthesia with mechanical ventilation or thoracic neuraxial anesthesia combined with non-GABAergic sedation while maintaining spontaneous breathing.

The primary objective is to evaluate the feasibility in terms of recruitment of a RCT conducted in a population of frail or cognitively impaired patients undergoing major laparoscopic abdominal surgery, randomized to a neuraxial or general anesthetic approach in which the effects on the onset of postoperative delirium and postoperative cognitive dysfunction (POCD) will be determined. Secondary outcomes include the occurrence of postoperative organ dysfunction (respiratory, cardiovascular, renal, and metabolic), length of hospital stay, time to recovery after surgery, and postoperative mortality.

Patients will undergo comprehensive perioperative clinical, laboratory, and ultrasound assessments, including lung and renal ultrasound evaluations. Neurological and functional status will be assessed during hospitalization, at 1 month, and via telephone follow-up at 1 year after surgery.

The aim of the study is to evaluate the feasibility and safety of performing two different anesthetic techniques on fragile patients.

02

Conditions studied

  • Fraily
  • Abdominal Surgery
  • Postoperative Cognitive Dysfunction (POCD)

Keywords

  • neuraxial anesthesia
  • awake surgery
  • frailty
  • postoperative delirium
  • cognitive outcomes
  • perioperative medicine
  • enhanced recovery after surgery
03

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age > 60 years
  • Willingness to participate in the study and written informed consent
  • ASA physical status > 2
  • Frailty score > 5 and/or AMT-10 \< 6
  • Laparoscopic or robotic major elective abdominopelvic surgery

Exclusion criteria

Exclusion Criteria:

  • Patients undergoing open (laparotomic) or emergency surgery, or presenting contraindications to central locoregional (neuraxial) anesthesia, specifically:

    • coagulation disorders
    • severe spinal deformities
    • known allergy to local anesthetics
    • severe aortic stenosis
    • systemic sepsis
    • infection at the puncture site
  • Any systemic disease that, in the investigator's judgment, is not compatible with participation in the study
04

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    neuraxial anesthesia combined with sedation

    patients are submitted to laparoscopic or robotic abdominopelvic surgery with a neuraxial anesthesia combined with sedation.

    Procedure: Neuraxial anesthesia · Drug: avoidance of GABAergic-drugs strategy

  • Active comparator
    General anesthesia

    patients are submitted to laparoscopic or robotic abdominopelvic surgery undergoing a general anesthesia.

    Procedure: General Anesthesia · Drug: use of GABAergic-drugs · Procedure: mechanical ventilation (MV)

Interventions

  • ProcedureNeuraxial anesthesia

    patients undergo surgery with a neuraxial anesthesia based on spinal or epidural anesthesia using local anesthetics combined with sedation.

  • ProcedureGeneral Anesthesia

    patients undergo surgery with a general anesthesia using classical GABAergic-drugs.

  • Drugavoidance of GABAergic-drugs strategy

    Sedation based on dexmedetomidine and low dosage of ketamine, avoiding GABAergic-drugs

  • Druguse of GABAergic-drugs

    General anesthesia using classical GABAergic-drugs such as propofol, remifentanil and rocuronium.

  • Proceduremechanical ventilation (MV)

    Abdomino-pelvic Surgery managed in general anesthesia needs orotracheal intubation and mechanical ventilation

05

What researchers measure

Primary outcomes

  1. Number of patients effectively managed with neuraxial approach

    Evaluate feasibility in terms of number of patients recruited and number of patients randomized to neuraxial anesthetic approach effectively managed in neuraxial anesthetic approach throughout all the procedure.

    Time frame: Periprocedural

Secondary outcomes

  1. Postoperative cognitive disfunction

    Postoperative cognitive dysfunction will be assessed using the Montreal Cognitive assessment (MoCA). A MoCA score \> 26 will be considered normal, where as a score \< 26 will indicated cognitive dysfunction. Lower scores correspond to grater severity of detected cognitive impairment.

    Time frame: The moment of enrollement and at 30 days follow-up and one year.

  2. Postoperative delirium.

    Postoperative delirium will be assessed using 3D CAM, on a rating scale where a value of 0 indicates no delirium and a maximum value of 7 indicates the most severe degree.

    Time frame: The moment of enrollement, post operative 0,1,2,3 and day of discharge.

  3. Polmonary complications.

    Pulmonary complications will be assessed through a lung ultrasound (lung pocus), the score of which includes a minimum value of 0 representing normality and a maximum value of 36 describing the presence of widespread consolidation in all 12 lung areas explored.

    Time frame: The moment of enrollement, postoperative days 1,2,3.

  4. Renal function

    Postoperative renal function is assessed using the KDIGO score, where 1 represents mild renal insufficiency and 3 represents severe renal insufficiency.

    Time frame: Day of enrollement, postoperative days 1,2,3.

  5. In hospital lenght of stay

    Lenght of stay (n° days)

    Time frame: day of discharge (up to 1 month)

  6. Complications

    Occurence of short-and medium-term postoperative complications (Clavien -Dindo classification from grade 1 to grade 5).

    Time frame: up to 30 days and 1 year

  7. Recovery after surgery

    Day to recovery of oral intake (n°) Day to first mobilization (n°) These outcomes aim to evaluate the overall impact to ERAS principles.

    Time frame: From date of randomization until the date of first documented progression, assessed up to 1 month.

  8. Renal arterial perfusion

    Renal Doppler ultrasound is also performed, calculating the renal resistance index, which is normally \<0.7 (range 0-1)

    Time frame: Day of enrollment, postoperative days 1,2,3

  9. Renal congestion

    Renal Doppler ultrasound is also performed to assess venous congestion index, which is normally 0 (range 0-1).

    Time frame: day of enrollment, postoperative days 1,2,3

06

Study locations

2 sites
  • E.O. Ospedali Galliera
    Genova, 16128, Italy
    • Claudia Brusasco, MD, PhD · Contact · claudia.brusasco@galliera.it · 00393291185009
    • Marco Micali, Md · Sub investigator
    • Claudia Brusasco, MD, PhD · Principal investigator
    • Federico Germinale, MD · Sub investigator
    • Carlo Introini, Md · Principal investigator
    • Maura Marcucci, MD, PhD · Sub investigator
  • AO di Circolo di Melegnano
    Vizzolo Predabissi, 20070, Italy
07

References and documents

Individual participant data

Plan to share: Yes — We share the entire study protocol (English version) and the CRF (Italian version).

Supporting information: Study protocol, Csr

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07486336
Lead sponsor
Ente Ospedaliero Ospedali Galliera
Responsible party
Claudia Brusasco (MD PhD Anesthesiologist, Ente Ospedaliero Ospedali Galliera) — Principal investigator
First posted
Mar 20, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Sep 1, 2028 (estimated)
Completion
Jan 1, 2029 (estimated)
Last update
Mar 20, 2026

Study contacts

Claudia Brusasco, MD, PhD
Contact
claudia.brusasco@galliera.it
0039 3291185009

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion